Boston Scientific has received Food and Drug Administration (FDA) approval of its fourth-generation Vercise Genus Deep Brain Stimulation (DBS) System. Share this:TwitterFacebookLike this:Like Loading... You May Also Like Healthcare Technology 07-06-2023 Google Cloud, Mayo Clinic Partners on Generative AI Focused on Enterprise Search Healthcare Technology 17-02-2022 Patient Data & Decentralized Web: The Key To A Healthier Future? Healthcare Technology 28-02-2023 Five Effective Treatment to Recover from Back Pain Permanently Healthcare Technology 24-06-2021 Heywood, Middleton and Rochdale CCG rolls out digital consultation